{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:16:54Z","timestamp":1789183014578,"version":"build-2803163510"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T00:00:00Z","timestamp":1466553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AI100263"],"award-info":[{"award-number":["P01 AI100263"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI098446"],"award-info":[{"award-number":["R01 AI098446"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI095985"],"award-info":[{"award-number":["U19 AI095985"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AI073961"],"award-info":[{"award-number":["P30AI073961"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0158009","type":"journal-article","created":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T19:22:32Z","timestamp":1466623352000},"page":"e0158009","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Recombinant AAV Vectors for Enhanced Expression of Authentic IgG"],"prefix":"10.1371","volume":"11","author":[{"given":"Sebastian P.","family":"Fuchs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Martinez-Navio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Desrosiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,6,22]]},"reference":[{"issue":"1 1","key":"ref1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev-virology-031413-085355","article-title":"AAV-Mediated Gene Therapy for Research and Therapeutic Purposes","author":"RJ Samulski","year":"2014","journal-title":"Annual Review of Virology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/vaccines2030624","article-title":"Developments in Viral Vector-Based Vaccines","volume":"2","author":"T Ura","year":"2014","journal-title":"Vaccines"},{"key":"ref3","first-page":"1","article-title":"Viral vectors: a look back and ahead on gene transfer technology","volume":"36","author":"L Vannucci","year":"2013","journal-title":"New Microbiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.270.5235.475","article-title":"T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years","volume":"270","author":"RM Blaese","year":"1995","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"S Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrg3742","article-title":"Engineering adeno-associated viruses for clinical gene therapy","volume":"15","author":"MA Kotterman","year":"2014","journal-title":"Nat Rev Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/17425247.2014.871258","article-title":"The potential of adeno-associated viral vectors for gene delivery to muscle tissue","volume":"11","author":"D Wang","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1089\/hum.1996.7.9-1145","article-title":"A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease","volume":"7","author":"T Flotte","year":"1996","journal-title":"Hum Gene Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber's congenital amaurosis","volume":"358","author":"AM Maguire","year":"2008","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"AC Nathwani","year":"2011","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/mt.2011.237","article-title":"Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector","volume":"20","author":"DE Bowles","year":"2012","journal-title":"Mol Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(13)62117-0","article-title":"Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial","volume":"383","author":"RE MacLaren","year":"2014","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/gt.2012.43","article-title":"Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial","volume":"20","author":"D Gaudet","year":"2013","journal-title":"Gene Ther"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40265-014-0339-9","article-title":"Alipogene tiparvovec: a review of its use in adults with familial lipoprotein lipase deficiency","volume":"75","author":"LJ Scott","year":"2015","journal-title":"Drugs"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/humc.2013.087","article-title":"Lessons learned from the clinical development and market authorization of Glybera","volume":"24","author":"LM Bryant","year":"2013","journal-title":"Hum Gene Ther Clin Dev"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nm.1967","article-title":"Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys","volume":"15","author":"PR Johnson","year":"2009","journal-title":"Nat Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e1005090","DOI":"10.1371\/journal.ppat.1005090","article-title":"AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity","volume":"11","author":"SP Fuchs","year":"2015","journal-title":"PLoS Pathog"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature14264","article-title":"AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges","volume":"519","author":"MR Gardner","year":"2015","journal-title":"Nature"},{"key":"ref19","article-title":"Broadly neutralizing human immunodeficiency virus type 1 antibody gene transfer protects non-human primates from mucosal simian-human immunodeficiency virus infection","author":"KO Saunders","year":"2015","journal-title":"J Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nature10660","article-title":"Antibody-based protection against HIV infection by vectored immunoprophylaxis","volume":"481","author":"AB Balazs","year":"2012","journal-title":"Nature"},{"key":"ref21","article-title":"Host Anti-antibody Responses Following AAV-Mediated Delivery of Antibodies against HIV and SIV in Rhesus Monkeys","author":"JM Martinez-Navio","year":"2015","journal-title":"Mol Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/mt.2008.171","article-title":"Self-complementary AAV vectors; advances and applications","volume":"16","author":"DM McCarty","year":"2008","journal-title":"Mol Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","article-title":"Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis","volume":"8","author":"DM McCarty","year":"2001","journal-title":"Gene Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/hum.2006.088","article-title":"Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity","volume":"18","author":"J Wu","year":"2007","journal-title":"Hum Gene Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1128\/JVI.05848-11","article-title":"Single-chain Fv-based anti-HIV proteins: potential and limitations","volume":"86","author":"AP West Jr.","year":"2012","journal-title":"J Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.1128\/JVI.76.17.8769-8775.2002","article-title":"Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer","volume":"76","author":"AD Lewis","year":"2002","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1006\/mthe.2000.0050","article-title":"IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector","volume":"1","author":"H Mizuguchi","year":"2000","journal-title":"Mol Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nbt1087","article-title":"Stable antibody expression at therapeutic levels using the 2A peptide","volume":"23","author":"J Fang","year":"2005","journal-title":"Nat Biotechnol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/sj.mt.6300142","article-title":"An antibody delivery system for regulated expression of therapeutic levels of monoclonal antibodies in vivo","volume":"15","author":"J Fang","year":"2007","journal-title":"Mol Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/gt.2008.90","article-title":"Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition","volume":"15","author":"S Yang","year":"2008","journal-title":"Gene Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/bit.22933","article-title":"C-terminal lysine processing of human immunoglobulin G2 heavy chain in vivo","volume":"108","author":"B Cai","year":"2011","journal-title":"Biotechnol Bioeng"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1128\/JVI.73.4.2886-2892.1999","article-title":"Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors","volume":"73","author":"R Zufferey","year":"1999","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1756-6606-7-17","article-title":"Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons","volume":"7","author":"JH Choi","year":"2014","journal-title":"Mol Brain"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"7827","DOI":"10.1073\/pnas.0802866105","article-title":"Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses","volume":"105","author":"L Zhong","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1038\/mt.2010.172","article-title":"High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines","volume":"18","author":"DM Markusic","year":"2010","journal-title":"Mol Ther"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"14002","DOI":"10.1038\/mtm.2014.2","article-title":"Systemic gene transfer reveals distinctive muscle transduction profile of tyrosine mutant AAV-1, -6, and -9 in neonatal dogs","volume":"1","author":"CH Hakim","year":"2014","journal-title":"Mol Ther Methods Clin Dev"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/hum.2010.003","article-title":"Adeno-associated virus serotype 6 capsid tyrosine-to-phenylalanine mutations improve gene transfer to skeletal muscle","volume":"21","author":"C Qiao","year":"2010","journal-title":"Hum Gene Ther"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1089\/hum.2011.053","article-title":"Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing alpha1-antitrypsin: interim results","volume":"22","author":"TR Flotte","year":"2011","journal-title":"Hum Gene Ther"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa1407309","article-title":"Long-term safety and efficacy of factor IX gene therapy in hemophilia B","volume":"371","author":"AC Nathwani","year":"2014","journal-title":"N Engl J Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood-2004-06-2501","article-title":"Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer","volume":"105","author":"VM Rivera","year":"2005","journal-title":"Blood"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"16363","DOI":"10.1073\/pnas.0904514106","article-title":"Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy","volume":"106","author":"ML Brantly","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1128\/JVI.00526-06","article-title":"High-level transgene expression in nonhuman primate liver with novel adeno-associated virus serotypes containing self-complementary genomes","volume":"80","author":"GP Gao","year":"2006","journal-title":"J Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/sj.gt.3302134","article-title":"Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo","volume":"10","author":"DM McCarty","year":"2003","journal-title":"Gene Ther"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/sj.gt.3302133","article-title":"Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo","volume":"10","author":"Z Wang","year":"2003","journal-title":"Gene Ther"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/sj.mt.6300355","article-title":"Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose","volume":"16","author":"Z Wu","year":"2008","journal-title":"Mol Ther"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.gt.3302417","article-title":"Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE)","volume":"12","author":"SM Kingsman","year":"2005","journal-title":"Gene Ther"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.gt.3302698","article-title":"Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression","volume":"13","author":"A Schambach","year":"2006","journal-title":"Gene Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response","volume":"12","author":"CS Manno","year":"2006","journal-title":"Nat Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nm1549","article-title":"CD8(+) T-cell responses to adeno-associated virus capsid in humans","volume":"13","author":"F Mingozzi","year":"2007","journal-title":"Nat Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"9993","DOI":"10.1128\/JVI.77.18.9993-10003.2003","article-title":"Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities","volume":"77","author":"WE Johnson","year":"2003","journal-title":"J Virol"},{"key":"ref51","doi-asserted-by":"crossref","DOI":"10.1002\/9780471729259.mc14d01s26","article-title":"Production and discovery of novel recombinant adeno-associated viral vectors","author":"C Mueller","year":"2012","journal-title":"Curr Protoc Microbiol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1743-422X-2-43","article-title":"Adeno-associated virus: from defective virus to effective vector","volume":"2","author":"MA Goncalves","year":"2005","journal-title":"Virol J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0158009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T15:05:06Z","timestamp":1600787106000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0158009"}},"subtitle":[],"editor":[{"given":"John A","family":"Chiorini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,22]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0158009","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,22]]}}}